Evidence map›Paper›PMID 18223697›Full record

ReviewBone marrow transplantation2008

Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction.

M C Bunte, M M Patnaik, M R Pritzker, L J Burns

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bone marrow transplantation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Identification of pulmonary arterial hypertension patients with venous or capillary involvement.American journal of respiratory and critical care medicine · 2026
    Article
  4. Article
  5. Pulmonary veno-occlusive disease: a clinical review.Breathe (Sheffield, England) · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Noninfectious complications of hematopoietic cell transplantation.Hematology. American Society of Hematology. Education Program · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Noninfectious pulmonary complications of haematopoietic stem cell transplantation.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
  18. Tumoral pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  19. Article
  20. Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M C BunteDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
M M Patnaik
M R Pritzker
L J Burns

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Veno-occlusive disease is among the most serious complications following hematopoietic stem cell transplantation. While hepatic veno-occlusive disease occurs more commonly, the pulmonary variant remains quite rare and often goes unrecognized antemortem. Endothelial damage may represent the pathophysiologic foundation of these clinical syndromes. Recent advances in the treatment of hepatic veno-occlusive disease may have application to its pulmonary counterpart.

Indexed as

EndotheliumFibrinolytic AgentsHematopoietic Stem Cell TransplantationHumansPolydeoxyribonucleotidesPulmonary Veno-Occlusive DiseasedefibrotideFibrinolytic AgentsPolydeoxyribonucleotides

Identifiers

PMID18223697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.